Tapewire

Nasdaq · USD

RXRX

RECURSION PHARMACEUTICALS, INC.

Export transactions ↓
Tapewire entity
1008
SEC CIK
0001601830
Parsed reports
506

Last 12 months

Inside the activity.

0 purchase rows · 35 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202502
Dec 202505
Jan 202603
Feb 202604
Mar 202604
Apr 202603
May 202603
Jun 202605
Jul 202601
Aug 202601
Sep 202602
Oct 202602

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
April 15, 2021 Filed Apr 19, 2021 23:21 UTC GrantStock Option (Right to Buy) · Derivative 12,500 $0.00 Strike: $18.00 $0.00
Disclosure

SEC source: 0001209191-21-027389 · doc4.xml · derivative · entry 2

Borgeson Blake · CIK 0001856094 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,500

Underlying: Common Stock · 12,500 shares

Expires 2031-04-14

F3 · derivative.exercise_date: The option becomes exercisable as to all of the shares subject to the option on the earlier of April 15, 2022 and the Issuer's first annual stockholder meeting.

F1 · derivative.underlying: Immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock, each share of Common Stock shall be reclassified into one share of Class A Common Stock. Each share of Series A Preferred Stock, Series A-1 Preferred Stock, Series B Preferred Stock and Series D Preferred Stock shall automatically convert into Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock and has no expiration date. Each share of Series C Preferred Stock shall automatically convert into Common Stock on a 1.1869358:1 basis immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock and has no expiration date.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.